Jump to navigation

phrma
phrma

Investing in innovative medicines that improve
and extend the lives of millions

Watch More Videos

Slide Show
Slide Show
  •  Matthias von Herrath, MD of Novo Nordisk
  • Alzheimer's: The Science behind a cure
  • A Caregiver's Story: Alzheimer's is a Cruel Disease
  • It Started with Pancakes: Alzheimer's Through the Eyes of a Researcher & Caregiver
  • Cancer Survivor Susan Parkinson talks about her battle with Non-Hodgkin's Lymphoma
  • Clinical Trials – from Company through FDA to Patient
  • Targeting Rare Diseases
  • Biotechnology: Learn about New Biological Medicines in Development
  • Medicines in Development for Cancer: A Timeline
  • Medicare Part D – the Prescription Drug Plan – is Working for Seniors
  • Learn About New Medicines in Development to Treat Arthritis
  • Arthritis
  • Fighting HIV:AIDS
  • New Medicines in Development for Women
  • The Best Preparation for the Worst Asthma Attack
  • Juvenile Rheumatoid Arthritis (JRA) Affects 300,000 Kids; Learn About Therapies and Treatments
  • Recipe for Hope
  • Alzheimer's Disease: Finding a Cure
  • Learn More About Alzheimer's Disease Research in 2010, What's Being Done
  • From Hope to Cures - John Castellani Intro
  • Elizabeth Zabell Edelman of Diabetes Daily talks to PhRMA
  • Impact of Alzheimer's Disease

Innovations and InaugurationsRead Innovations and Inaugurations: A Look Back

  • Research »
    In 2011, PhRMA member companies invested more than $50 billion in R&D to help develop innovative medicines for patients.
  • Progress »
    We’re improving patients’ health while cutting their healthcare costs, thanks to 370 recently developed new medicines and therapies.
  • Hope »
    We’re more committed than ever to developing treatments and cures for all diseases, with more than 3,000 medicines in development, to help patients live normal lives.

Save the date: Biopharmaceutical Pipeline Webinar January 17

Tweet

Send us your stories, videos & tweets

Twitter Cloud

Twitter Feed

© PhRMA 2012. All Rights reserved. PhRMA.org Privacy Policy